Indeling en gradering van gliale tumoren

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 6, 1996, Pages 292-297

  Kros, J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; SHORT SURVEY;

ASTROCYTOMA; BIOPSY; BRAIN NEOPLASMS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY;

EID: 0030042830     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Zülch KJ, Wechsler W. Pathology and classification of gliomas. Progr Neurol Surg 1968:2:1-84.
2. Kleihues P, Burger PC, Scheithauer BW. (WHO) Histological typing of tumours of the central nervous system. 2nd ed. Berlin: Springer-Verlag. 1993.
3. Bailey P. Cushing H. A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia: Lippincott. 1926.
4. Scherer H-J. A critical review. The pathology of cerebral gliomas. J Neurol Neurosurg Psychiatry 1940:3:147-77.
5. Khominsky BS Grades of malignancy of tumours of neuroectodermal origin. Neoplasma 1969:16:651-66.
6. Kernohan JW, Mabon RF, Svien HJ, Adson AW. A simplified classification of the gliomas. Proc Staff Meet Mayo Cllin 1949:24:71-5.
7. Broders AC. The grading of carcinoma. Minn Med 1925:8:726-30.
8. Ringertz N. 'Grading' of gliomas Acta Pathol Scand (Copenh) 1950: 27:51-64.
9. Kuhlendahl H, Miltz H, Wüllenweber R. Die Astrozytome des Grosshirns. Untersuchung zur Gruppierung und Prognose. Acta Neurochir (Wien) 1973:29:151-62.
10. Martin H, Schmidt D. Malignitätsgrading glioser Tumoren, I. Astrozytome. Zentralbl Allg Pathol 1985:130:451-62.
11. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988:62: 2152-65.
12. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW. Grading of oligodendrogliomas. Cancer 1983:52:2107-14.
13. Mork SJ, Loken AC. Ependymoma: a follow-up study of 101 cases Cancer 1977:40:907-15.
14. Afra D, Muller W, Slowik F, Wilcke O, Budka H, Turoczy L. Supratentorial lobar ependymomas: reports on the grading and survival periods in 80 cases, including 46 recurrences. Acta Neurochir (Wien) 1983:69:243-51.
15. Hedley-Whyte ET. Histological prediction of malignancy. Clin Neurosurg 1978.25.342-5.
16. Nelson JS, Tsukada Y, Schoenfeld D, Fulling K, Lamarche J, Peress N. Necrosis as a prognostic criterion in malignant supratentorial. astrocytic gliomas. Cancer 1983:52:550-4.
17. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC jr, Bullard DE. Clinicopathologic correlations in the oligodendroglioma. Cancer 1987:59:1345-52.
18. Lindegaard KF, Mork SJ, Eide GE, Halvorsen TB, Hatlevoll R, Solgaard T. et al. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma J Neurosurg 1987:67:224-30.
19. Germano IM, Ito M, Cho KG, Hoshino T, Davis RL, Wilson CB. Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 1989;70:701-6
20. Daumas-Duport C. Histological grading of gliomas. Curr Opin Neurol Neurosurg 1992:5:924-31.
21. Paulus W, Peiffer J, Intratumoral histologic heterogeneity of gliomas. A quantitative study Cancer 1989.64:442-7.
22. Finkelstein SD. CT-guided stereotactic biopsy of brain tumors: pathologic considerations. Am J Clin Oncol 1987:10:289-92.
23. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendrogliomas-astrocytomas with PCV chemotherapy. J Neurosurg 1992: 76:7411-5.
24. Macdonald DR. Low-grade gliomas. mixed gliomas. and oligodendrogliomas. Semin Oncol 1994:21:236-48.
25. Rubinstein LJ, Inaugural Dorothy S, Russell memorial lecture. Immunohistochemical signposts - not markers - in neural tumour diflerentiation. Neuropathol Appl Neurobiol 1986:12:523-37.
26. Perentes E, Rubinstein LJ. Recent applications of immunoperoxidase histochemistry in human neuro-oncology. An update. Arch Pathol Lab Med 1987:111:796-812.
27. Collins VP, James CD. Molecular genetics of primary intracranial tumors. Curr Opin Oncol 1990:2:666-72
28. Wong AJ, Zoltick PW, Moscatello DK. The molecular biology and molecular genetics of astrocytic neoplasms Semin Oncol 1994:21: 139-48.
29. Batra SK, Rasheed BKA, Bigner SH, Bigner DD. Oncogenes and anti-oncogenes in human central nervous system tumors. Lab Invest 1994:71-621-37
30. Bigner SH, Mark J, Bigner DD. Cytogenetics of human brain tumors Cancer Genet Cytogenet 1990:47:141-54.
31. Bigner SH, Burger PC, Wong AJ, Werner MH, Hamilton SR, Muhlbaier LH. et al. Gene amplification in malignant human gliomas. clinical and histopathologic aspects. J Neuropathol Exp Neurol 1988: 47:191-205.
32. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994:81:427-36.
33. Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J. et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995:54.91-5.